VI
Vir Biotechnology, Inc.
VIR · NASDAQ
$10.77 +0.33% (+$0.04)
1M +13.10%
Market Cap $1.82B
P/E Ratio -
Div. Yield -
ROE 29.99%
Bulios Fair Price
$7.99
25.8% downside
Trenutna cena
$10.77
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VIR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
58 /100
Fair P/B 1.85x
P/S 5.99x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 28.32%
Rev. growth 65.12%
FCF growth N/A
Profitability
20 /100
Weak Net margin 83.00%
Op. margin 88.97%
FCF margin 109.34%
Quality
3 /100
Poor ROE 29.99%
ROA 20.72%
Asset turnover 0.25x
Debt
100 /100
Low Current ratio 6.04x
Debt/Equity 0.09x
Net debt/EBITDA N/A
Stability
7 /100
Unstable Rev. volatility 48.55%
EPS volatility 136.76%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VIR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marianne De Backer
Employees
367
Headquarters
San Francisco
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report